Pulmagen’s clinical and preclinical pipeline of therapies for chronic respiratory diseases such as COPD, asthma and cystic fibrosis delivers both symptomatic relief (bronchodilators) and a disease modifying effect (anti-inflammatory).
Location: United Kingdom, England, Slough
Investors 1
| Date | Name | Website |
| - | Forbion | forbion.co... |
Mentions in press and media 1
| Date | Title | Description | Source |
| 14.12.2016 | Pfizer inks an early-stage collaboration deal as it in... | A busy Pfizer is partnering with South San Francisco-based Ab Initio Biotherapeutics on th... | endpts.com... |